Semi-Annual Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7310662

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-793,371,000 JPY
-900,989,000 JPY
Non-operating income
Non-operating income
49,593,000 JPY
35,765,000 JPY
Non-operating expenses
Non-operating expenses
9,219,000 JPY
2,217,000 JPY
Ordinary profit (loss)
-752,997,000 JPY
-867,441,000 JPY
Extraordinary income
Extraordinary income
JPY
136,000 JPY
Profit (loss) before income taxes
-752,997,000 JPY
-867,305,000 JPY
Income taxes - current
1,871,000 JPY
1,457,000 JPY
Profit (loss)
-754,868,000 JPY
-868,762,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.